NCT04998864 2026-04-16
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients
InSightec
Completed
Clinical Trials
20 trialsNCT07238322 2026-02-20
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
Telix Pharmaceuticals (Innovations) Pty Limited
Active not recruiting
NCT07366892 2026-01-26
IMED-GLOW400
Leica Microsystems (Schweiz) AG
Not yet recruiting
NCT07240662 2026-01-09
VIOLETA
iOMEDICO AG
Recruiting
NCT07164053 2025-11-20
IMED-MYVEO
Leica Microsystems (Schweiz) AG
Not yet recruiting
NCT06038760 2025-07-30
PEAR-GLIO
Ourotech, Inc.
Terminated
NCT06969352 2025-05-13
VICTORIA
Servier (Tianjin) Pharmaceutical Co. LTD.
Not yet recruiting
NCT05305378 2024-08-07
Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow
Dynamic Light
Completed
NCT05958472 2023-07-24
Navigating the Clinical Research Process for Glioma
Power Life Sciences Inc.
Not yet recruiting
NCT05656053 2023-03-17
Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging
Mingge LLC
Active not recruiting
NCT05739500 2023-02-22
MRI-based Computer Aided Diagnosis Software (V1) for Glioma
Mingge LLC
Unknown
NCT03793088 2023-02-03
XCELSIOR
xCures
Unknown
NCT05100173 2021-11-22
Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
Genetron Health
Completed
NCT05100602 2021-11-22
Clinical Evaluation of Genetron TERT PCR Kit in Glioma Patients
Genetron Health
Completed
NCT02300506 2018-11-05
Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma
Eisai Inc.
Completed
NCT02300532 2017-02-27
Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)
Eisai Inc.
Completed
NCT00705198 2016-11-15
Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)
Merck Sharp & Dohme LLC
Completed
NCT01138813 2015-10-12
MRS Tumor
Merck Sharp & Dohme LLC
Completed
NCT00723827 2015-01-30
Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)
Merck Sharp & Dohme LLC
Completed
NCT00561873 2007-11-21
Nimotuzumab in Children With HGG
Oncoscience AG
Completed